5 YEARS COSMETIC OUTCOME AFTER INTENSITY MODULATED RADIATION THERAPY FOLLOWED CONSERVATIVE SURGERY OF BREAST CANCER STAGE I-II AT K HOSPITAL
Main Article Content
Abstract
Breast cancer is the most common cancer in women. While conservative treatment is indicated for early stage breast cancer (stage I-II), adjuvant radiation therapy is mandatory. Forward intensity modulated radiotherapy (F-IMRT) is a modern radiation technique by using LINAC with multileaf collimator system to optimize radiation treatment plan in order to improve homogeneity of PTV, minimizing the dose to organ at risks. Our study aims to review clinical features and 5 years cosmetic outcome after F-IMRT followed breast cancer conservative treatment of at K hospital. Objectives and methods: 68 eligible patients with stage I-II breast cancer were selected, treated by forward IMRT followed conservative surgery from 2/2016 to 10/2021 at K Hospital. Review clinical features and estimate cosmetic outcome at the end of 5 years postoperative radiotherapy. Result: Clinical features of 68 eligible patients: median age is 44; the lowest is 21; tumor location: left breast accounted for 61.2%, upper outer quadrant of the breast is most common (64.2%). TNM stage: mostly stage I-IIA (91.2%); Breat volume: most patients with small and average breast volume (90.3%). The 5-year disease-free survival (DFS) rates are 92.6%. The 5- years overall survival (OS) rates is 95.6%. Quality of cosmetic outcome account for 80.2% (Excellent: 37.6%; Good: 20.8%; Fair: 21.8%). Conclusion: In our study, the 5-year disease-free survival was 92.6%, the 5-year overall survival was 95.6%. we found that high rate of fair, good and excellent cosmetic result group reached 80.2%. The side effects of radiation therapy that affect cosmetic results often occur late, so long-term follow-up after treatment is required for more accurate conclusions.
Article Details
References
2. Harsolia A, Kestin L, Grills I, Wallace M, Jolly S, Jones C, et al. "Intensity-modulated radiotherapy 2. results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy"". Int J Radiat Oncol Biol Phys. 2007;68(5):1375-80.
4. Losken, C. S. Dugal, T. M. Styblo et al. (2014). A meta-analysis comparing breast conservation therapy alone to the oncoplastic technique. Ann Plast Surg, 72(2), 145 - 152
5. Phạm Hồng Khoa (2016). Ứng dụng phương pháp sinh thiết hạch cửa trong điều trị ung thư biểu mô tuyến vú giai đoạn sớm, Luận án Tiến sỹ Y học, Trường Đại học Y Hà Nội.
6. J. P. Pignol, I. Olivotto, E. Rakovitch et al. (2008). A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol, 26(13), 2085-92.
7. Tạ Văn Tờ (2004). Nghiên cứu hình thái học, hóa mô miễn dịch và giá trị tiên lượng của chúng trong ung thư biểu mô tuyến vú, Luận án Tiến sỹ Y học, Trường Đại học Y Hà Nội.
8. U. Veronesi, A. Luini, M. Del Vecchio et al. (1993). Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med, 328(22), 1587-91.
9. Hoàng Thanh Quang (2011). Đánh giá kết quả điều trị bảo tồn ung thư vú nữ giai đoạn I-II từ năm 2003-2006 tại Bệnh viện K, Luận văn Thạc sỹ Y học, Trường Đại học Y Hà Nội.